Ibrahim A Abdelwahab

Dr. Ibrahim A Abdelwahab

Pharos University in Alexandria, Alexandria, Al Iskandarīyah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
OSOmaima G. Shaaban
Omaima G. Shaaban
DIDoaa A.E. Issa
Doaa A.E. Issa
AEAlaa A. El-Tombary
Alaa A. El-Tombary
SWShrouk M. Abd El Wahab
Shrouk M. Abd El Wahab
AWAbeer E. Abdel Wahab
Abeer E. Abdel Wahab
IAIbrahim A Abdelwahab
Ibrahim A Abdelwahab

1 February 2018 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MEMaryam A.Z. El-Attar
Maryam A.Z. El-Attar
RERasha Y. Elbayaa
Rasha Y. Elbayaa
OSOmaima G. Shaaban
Omaima G. Shaaban
NHNargues S. Habib
Nargues S. Habib
AWAbeer E. Abdel Wahab
Abeer E. Abdel Wahab
SESoad A.M. El-Hawash
Soad A.M. El-Hawash

5 September 2020 in The Open Microbiology Journal
Verified
Journal Article
Open access
PDF file
RARania Abozahra
Rania Abozahra
SASarah M. Abdelhamid
Sarah M. Abdelhamid
MWMing Ming Wen
Ming Ming Wen
IAIbrahim A Abdelwahab
Ibrahim A Abdelwahab
KBKholoud Baraka
Kholoud Baraka
Background: Klebsiella pneumoniae is a nosocomial pathogen in outbreaks of hospital infections. It is one of the major factors for morbidity and mortality in hospitalized patients especially those infected with colistin-resistant pathogens. Many plant essential oils have antimicrobial activities and have been investigated as natural sources to combat multiple antibiotic resistances. Moreover, recent advances in phytonanotechnology have created exciting opportunities for the management of many infections. Objective: This study aims at investigating the antimicrobial and antibiofilm effect of rosemary and ginger essential oil-based nano-sized formulations on colistin resistant K. pneumonia clinical isolates. Methods: Isolation and identification of 30 K. pneumonia isolates from different human samples were done followed by antibiotic susceptibility testing and detection of biofilm gene (mrkD). Examination of the activity of the tested essential oils and their chitosan nanoparticle formulations against the selected isolates was made by determination of their MICs using broth microdilution method followed by biofilm inhibition test and quantitative real-time PCR for the expression of mrkD gene in the presence of the oils and nanoparticles formulations compared to untreated bacterial isolates. Results: Our results showed that the minimum inhibitory concentration of rosemary and ginger oils was 1250 μg/ml, that of nanostructured lipid carrier-rosemary oil and nanostructured lipid carrier-ginger oil was 625 μg/ml and rosemary oil loaded chitosan nanoparticles and ginger oil loaded chitosan nanoparticles possessed minimum inhibitory concentration of 156 μg/ml. Results also revealed complete (100%) inhibition for mrkD gene expression when compared to untreated K. pneumonia. Conclusion: Oil loaded chitosan nanoparticles showed the highest antimicrobial and antibiofilm activity.

7 August 2019 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
OROla Hassan Rizk
Ola Hassan Rizk
MBMohamed G. Bekhit
Mohamed G. Bekhit
AHAly A. B. Hazzaa
Aly A. B. Hazzaa
EEEl‐Sayeda M. El‐Khawass
El‐Sayeda M. El‐Khawass
IAIbrahim A Abdelwahab
Ibrahim A Abdelwahab

8 August 2018 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
MEMaryam A Z El-Attar
Maryam A Z El-Attar
RERasha Y Elbayaa
Rasha Y Elbayaa
OSOmaima G Shaaban
Omaima G Shaaban
NHNargues S Habib
Nargues S Habib
AWAbeer E Abdel Wahab
Abeer E Abdel Wahab
SESoad A M El-Hawash
Soad A M El-Hawash
Aim: The development of a new class of antimicrobial agents is the optimal lifeline to scrap the escalating jeopardy of drug resistance. Experimental: This study aims to design and synthesize a series of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines, to develop agents having antimicrobial activity through potential inhibition of dihyropteroate synthase enzyme. The target compounds have been evaluated for their in-vitro antimicrobial activity. Results & discussion: Compounds 5b, 5c were equipotent (minimal inhibitory concentration = 12.5 μg/ml) to ampicillin. The docking patterns of 5b and 5c demonstrated that both fit into Bacillus Anthracis dihydropteroate synthase pterin and p-amino benzoic acid-binding pockets. Moreover, their physicochemical properties and pharmacokinetic profiles recommend that they can be considered drug-like candidates. The results highlight some significant information for the future design of lead compounds as antimicrobial agents. Graphical abstract

3 January 2022 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
MYMarwa A. Yakout
Marwa A. Yakout
IAIbrahim A Abdelwahab
Ibrahim A Abdelwahab
During the different waves of the coronavirus (COVID-19) pandemic, there has been an increased incidence of diabetes mellitus and diabetic foot infections. Among gram-negative bacteria, Pseudomonas aeruginosa is the predominant causative agent for diabetic foot ulcer infections in low-resource countries. P. aeruginosa possesses a variety of virulence factors, including biofilm formation. Biofilm formation is an important benchmark characteristic in the pathophysiology of diabetic foot ulceration. The main objective of the current study was to identify the most commonly isolated organisms and their antibiotic susceptibility patterns in diabetic foot patients during the COVID-19 pandemic. We also determined the genes associated with bacterial persistence and biofilm formation in the predominantly isolated organism. Accordingly, 100 wound swab samples were collected from diabetic foot patients from different hospitals in Alexandria, Egypt. Through phenotypic detection of biofilm formation, 93% (40) of the 43 P. aeruginosa isolates examined were categorized as biofilm producers. Molecular detection of the biofilm-encoding genes among the 43 P. aeruginosa isolates was as follows: algD (100%), pelF (88%) and pslD (49.7%), and this highlights a need for biofilm formation inhibitors to prevent the persistence of bacterial pathogens, and thus achieve better clinical outcomes in diabetic foot ulcer infections.